hypercoagulable – Page 8 – Communicable Diseases Research

COVID-19 Thrombosis: Bridging the Old and New Concepts

Review Article

Published on 2021-02-242022-10-30
Journal: The Malaysian Journal of Medical Sciences : MJMS [Category] COVID-19,

High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?

높은 D 이량체와 낮은 글로벌 섬유소 용해는 COVID19 환자에서 공존합니다. 거기에서 무슨 일이 일어나고 있습니까?

Clinical Trial

Published on 2021-02-012022-09-11
Journal: Journal of Thrombosis and Thrombolysis [Category] SARS, 임상, 치료기술,

[키워드] Adult patient Adult patients approval calculated characterized clinical clot Coagulation coagulation test Coagulopathy correlation Course COVID COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients COVID19 D dimer D-dimer D-dimer level D-dimer levels detect diagnosed with COVID-19 Disseminated intravascular coagulation England enrolled ethics committee fibrinogen fibrinolysis fibrinolytic high mortality hypercoagulable Hypercoagulable state Hypothesis ICU ICU admission increase in Inpatient intravascular coagulation Laboratory Lancet London lung Lungs marker median morbidity Mortality normal range occur Organ failure paradoxical parameter Patient performed pilot study Platelet Platelet count retrospective cohort study risk factor Risk factors sample collection Sepsis sepsis-induced coagulopathy Septic shock Sequential Organ Failure Assessment Severe COVID-19 Infection severely ill COVID-19 patients SOFA SOFA score therapeutic anticoagulation Thromboelastometry thromboembolic Thromboembolic event Thromboembolic events Venous Thromboembolism were excluded while with COVID-19 Wuhan
[DOI] 10.1007/s11239-020-02226-0 PMC 바로가기 [Article Type] Clinical Trial

COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness

COVID-19: 심각한 질병과 관련된 과응고 상태를 촉진하기 위한 과도한 사이토카인 방출 및 잠재적인 ACE2 하향 조절의 역할

Review

Published on 2021-02-012022-09-11
Journal: Journal of Thrombosis and Thrombolysis [Category] 바이오마커, 치료기술,

[키워드] ACE2 ACE2 expression activity acute respiratory syndrome addition Analysis angiotensin Angiotensin-converting enzyme angiotensin-converting enzyme 2 anti-inflammatory cytokines association Clinical studies clinical study coronavirus coronavirus disease COVID-19 COVID-19 patients COVID-19 severity cytokine cytokine release Cytokines down-regulated down-regulation downregulated Effect Elevation enhancement Evidence Excessive cytokine release expression foster hypercoagulable Hypercoagulable state incidence Infectious disease Inflammatory response manifested marker mechanism Novel coronavirus novel coronavirus disease pathogenic mechanism pathogenic mechanisms poor prognosis present prevalent pro-inflammatory pro-thrombotic promote recent reduced respiratory retrospective Serum level serum levels Severe case severe cases severity severity of COVID-19 suggested thrombosis thrombotic thrombotic event Thrombotic events Treatment Vascular vascular thrombosis Vascular thrombotic events. virus with COVID-19
[DOI] 10.1007/s11239-020-02224-2 PMC 바로가기 [Article Type] Review

Aortic Arch Thrombus and Pulmonary Embolism in a COVID-19 Patient

COVID-19 환자의 대동맥궁 혈전 및 폐색전증

Case Reports

Published on 2021-02-012022-09-11
Journal: The Journal of emergency medicine [Category] 바이오마커,

[키워드] acute respiratory syndrome alteplase aortic arch aortic thrombus arch argatroban arterial thromboembolism Chest Chest radiography Computed tomography coronavirus coronavirus disease Coronavirus disease 2019 cough COVID-19 cytokine Cytokine storm D-dimer level distal Dyspnea elevated Embolism endothelial extremities Fever filling defects Ground-glass opacities healthy heparin hypercoagulable Hypercoagulable state hypercoagulable state. hypercoagulable states Infection Inflammation intensive care intensive care unit marker medical history moderate Mural normal past medical history patchy Patient positive pulmonary pulmonary arteries pulse oximetry respiratory resulting room air screened serum severe acute respiratory syndrome Coronavirus significantly subsegmental tested thromboembolic complications Thromboembolism Thrombus tomography treated unfractionated heparin venous viscera with COVID-19
[DOI] 10.1016/j.jemermed.2020.08.009 PMC 바로가기 [Article Type] Case Reports

The ADAMTS13-von Willebrand factor axis in COVID-19 patients

COVID-19 환자의 ADAMTS13-von Willebrand 요인 축

Article

Published on 2021-02-012022-09-11
Journal: Journal of thrombosis and haemostasis : JTH [Category] 바이오마커,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus ADAMTS13 ADAMTS13 Protein Admission Antigen Care characterized cofactor coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 patients COVID-19 progression cross-sectional cross-sectional study Deceased disease severity elevated ENhance Evidence evidence of hypercoagulable Hypercoagulable state Imbalance increased risk intensity lung Lungs mechanical ventilation mechanism median Microthrombosis microvasculature nasal nasal cannula Oxygenation Patient patients positive airway pressure propeptide ranged respiratory risk severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severe coronavirus disease stratified thromboembolic Thromboembolic events thrombosis von Willebrand factor vWF with intensity
[DOI] 10.1111/jth.15191 PMC 바로가기 [Article Type] Article

The Central Role of Fibrinolytic Response in COVID-19—A Hematologist’s Perspective

COVID-19에서 섬유소 용해 반응의 중심 역할 - 혈액 전문의의 관점

Review

Published on 2021-01-282022-09-12
Journal: International Journal of Molecular Sciences [Category] 진단,

[키워드] ACE acute respiratory diseases acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome aldosterone angiotensin angiotensin-converting enzyme 2 ARDS balance Characteristics contagious coronavirus coronavirus disease cough Course COVID-19 drug target Evidence fatigue Fever fibrinolysis fibrinolytic fibrinolytic system headache host cells hypercoagulable Hypercoagulable state Infection inhibitor involved kidney lesion lesions lung MERS Middle East Middle East respiratory syndrome Novel coronavirus novel coronavirus disease other organ other organs Pathogenesis pathway patients with COVID-19 plasminogen activator inhibitor 1 (PAI-1) pulmonary complications RAAS receptor Renin renin-aldosterone-angiotensin-system (RAAS) respiratory respiratory diseases respiratory distress Respiratory distress syndrome respiratory tract infection response role SARS-CoV-2 Severe acute respiratory syndrome severe pneumonia sore throat Spike protein spike protein of SARS-CoV-2 syndrome the spike protein tissue plasminogen activator Transmission uPA Urokinase-Type Plasminogen Activator Viral viral illnesses
[DOI] 10.3390/ijms22031283 PMC 바로가기 [Article Type] Review

Spontaneous ilio-psoas haematomas (IPHs): a warning for COVID-19 inpatients

Observational Study

Published on 2021-01-252022-10-04
Journal: Annals of Medicine [Category] SARS, 임상,

[키워드] Admission anticoagulant therapy anticoagulation anticoagulation treatment case sery change Comorbidity COVID-19 Critically ill patient Evidence heparin Hospitalization hypercoagulability hypercoagulable Hypoesthesia hypovolaemia ICUs Ilio-psoas haematoma incidence increased risk indication Infection Inpatient Inpatients intensive care unit Italy lack lower limbs material molecular observation period optimal dose over Pain Pneumonia reduce regimen reported Result Rome SARS-COV-2 infection SARS-CoV-2 pneumonia serious complication Seven severe COVID-19 Spontaneous subject Symptom the cytokine storm the SARS-CoV-2 therapy thrombosis thrombotic risk Treatment triggered with COVID-19
[DOI] 10.1080/07853890.2021.1875498 PMC 바로가기 [Article Type] Observational Study

Resolution of Disseminated Intravascular Coagulation in a Patient with COVID-19 and Associated Sepsis—Induced Neutropenia

Case Report

Published on 2021-01-242022-10-30
Journal: Medicina [Category] COVID-19, MERS,

Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies

COVID-19 환자의 항인지질 항체 및 면역 복합체: 항-아넥신-V 항체의 질병 경과에서의 추정 역할

Original Article

Published on 2021-01-192022-09-11
Journal: Clinical Rheumatology [Category] MERS, SARS, 진단, 치료기술,

[키워드] “COVID-19 Analysis Anti-phospholipid Anti-phospholipid antibodies antibodies antibody APL cause characterized CIC circulating circulating immune complexes Coagulopathy complement system complement system activation conditions control group COVID-19 COVID-19 patient Critical Critical illness Diagnosis digestive disease course distribution dysregulation early infection Endothelial cell endothelial cell damage evaluate glycoprotein group hypercoagulable Hypercoagulable state hypercoagulable states IgG immune complex immune dysregulation in some increases in Infection Inflammatory response Inflammatory responses inflammatory status knowledge lead negative control Pathogenesis Patient patients performed Point positive Prevalence pro-inflammatory prothrombin reported respiratory Result SARS-COV-2 infection significantly suggested syndrome thrombocytopenia thrombosis thrombotic Thrombotic complications Thrombotic events Trigger uniformity Viral viral infection viral infections worsening
[DOI] 10.1007/s10067-021-05580-3 PMC 바로가기 [Article Type] Original Article

COVID-19 Induced Bilateral Lower Limb Ischemia and Visceral Infarcts

Cardiac/Thoracic/Vascular Surgery

Published on 2021-01-192022-10-31
Journal: Cureus [Category] COVID-19,